about
Dietary advice for the prevention of type 2 diabetes mellitus in adultsDietary advice for the prevention of type 2 diabetes mellitus in adultsUsefulness of electronic databases for the detection of unrecognized diabetic patientsPrevalence, predisposition and prevention of type II diabetes.Continuous quality improvement in rural health clinicsPhysical activity in adults with and without diabetes: from the 'high-risk' approach to the 'population-based' approach of prevention.Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms.Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up studyCommunity-based randomized controlled trial of diabetes prevention study for high-risk individuals of type 2 diabetes: lifestyle intervention using web-based systemReduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysisUrinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuriaPrevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose toleranceComparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of AtherosclerosisVildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus.Combination ACE inhibitors and angiotensin II receptor blockers for hypertension.The economic impact of hypertension.Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistanceCost-effectiveness of an exercise program during pregnancy to prevent gestational diabetes: results of an economic evaluation alongside a randomised controlled trial.Exercise might improve cardiovascular autonomic regulation in adolescents with type 1 diabetes.Integrating chronic care with primary care activities: enriching healthcare staff knowledge and skills and improving glycemic control of a cohort of people with diabetes through the First Line Diabetes Care Project in the Philippines.Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program.Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.Preventing diabetes in the clinical setting.Reducing disparities for African Americans with diabetes: progress made by the REACH 2010 Charleston and Georgetown Diabetes CoalitionDiabetic kidney disease: impact of puberty.A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations?Counseling patients with type 2 diabetes and insulin resistance in the outpatient setting.Management of the patient with chronic renal failure in the evidence based era.Implications of the LIFE trial.Type 2 diabetes mellitus in youth.Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view.Who should be treated with combination therapy as initial treatment for hypertension?Glucose challenge test (50-g GCT) in detection of glucose metabolism disorders in peritoneal dialysis patients: preliminary study.2002 diabetes nutrition recommendations: grading the evidence.The pace of change in medical practice and health policy: collision or coexistence?Preventing type II diabetes mellitus.Peer chart audits: a tool to meet Accreditation Council on Graduate Medical Education (ACGME) competency in practice-based learning and improvement.Agents in development for the treatment of diabetic nephropathy.Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.
P2860
Q24186597-43CA80CC-2670-41EE-95C5-046DC1945A51Q24241999-B563C0E7-46B8-4258-B865-781EDA1B27FEQ24802056-0AFD3C08-4737-49D9-8561-51A49E210164Q24815863-BFCFBD9E-13D7-4BC7-9328-E513E6D93E63Q28188813-B5F41574-26DB-40BD-9320-18B108C2C56FQ31142279-8B58AC25-1438-4368-8F2E-036B1139127DQ33242098-8F35B94D-4809-4BBF-8D86-C3EE307EAC3AQ33371067-1A418D17-1ECB-41EC-9575-6F84FF8F5CC7Q33644745-7F3B49CF-56B7-473E-AE5F-4B8CC8F8F3EDQ33732227-5BA79F77-51F5-47BD-B753-DA16A8F3CE6EQ33735287-65F0CA9B-A5D8-4D80-9B62-B04E259AC8D1Q33793665-164A20E1-E3AB-4AA8-8E0B-139E37F7127FQ33880878-B6006A16-7B2E-4E30-8366-043133999773Q33973990-B84129E1-1EC2-4480-8BDC-3B5C981A2651Q34200885-0FAD881A-BE0A-40FB-A585-41DAD881E91EQ34209022-57BC64C5-64F0-4726-B468-477B9F68414EQ34245530-BDAB547C-5BFF-4BBF-920F-C9E87B3D315CQ34326866-3419966D-3397-4589-8D43-8B51B0DE0952Q34401286-76F49A2C-740F-4D03-958E-11671A882DFAQ34416580-5888197C-0D59-4628-B403-BC2A607B70EEQ34419127-7358C738-454B-45CD-B82E-33BB3E372A90Q34580041-01FDA3D7-3E67-4E98-AF8E-9E756EA65AD7Q34704057-6563D753-7B86-4C49-9D5F-7B23F45CEAF0Q34756686-6B27675C-6102-4A4F-AD92-C2BDD566CED3Q34826667-F3319FD7-FFDC-424B-A8B9-E5EBB2D06898Q35013827-6662E815-E0A1-4A47-B4BC-5E260F515B61Q35044470-A13F4E89-FE59-43C9-8A3F-6017B6371025Q35047912-984DFB36-CC6E-49D9-B573-588B8A1A8CFAQ35117105-E9480B98-E43D-4ADD-8746-05D6AB55F184Q35185731-FE7B715E-34C5-4DF2-8CCB-55AD39A62BABQ35202142-156F3346-2F18-4874-9EFF-87FFDDB35402Q35207039-BA063609-680F-4667-8581-1351F2B6A6EEQ35221069-542B5A5A-22A1-4866-BA59-14AE9978D358Q35588161-2D26FA8D-7E62-4D83-897F-88DCE6451775Q35638254-FF153F25-80A2-4D7B-91B6-EDD8A15380CCQ35722908-9A8DCFBF-44EE-439F-B63D-272586AD5FDBQ35963263-22AB0E84-788A-4D0F-BE9A-A8919D3C4C80Q36099419-524B43FF-00CB-40B6-AE4A-15CDA11C8927Q36302833-1E6490C7-C925-40FF-94EC-C81C9BB6A6A6Q36572819-B6902388-710D-47AD-B218-5FCD66B61E1C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The prevention or delay of type 2 diabetes.
@ast
The prevention or delay of type 2 diabetes.
@en
The prevention or delay of type 2 diabetes.
@nl
type
label
The prevention or delay of type 2 diabetes.
@ast
The prevention or delay of type 2 diabetes.
@en
The prevention or delay of type 2 diabetes.
@nl
prefLabel
The prevention or delay of type 2 diabetes.
@ast
The prevention or delay of type 2 diabetes.
@en
The prevention or delay of type 2 diabetes.
@nl
P356
P1433
P1476
The prevention or delay of type 2 diabetes.
@en
P2093
American Diabetes Association ...... Digestive and Kidney Diseases
P304
P356
10.2337/DIACARE.25.4.742
P407
P577
2002-04-01T00:00:00Z